THEMIS MEDICARE
|
The Current P/E Ratio of THEMIS MEDICARE is -38.85.
| Share Price | ₹101.7 | Dec 26,2025 |
| Market Cap | ₹936.7 Cr | |
| Earnings-TTM | ₹-24.1 Cr | TTM-Consolidated Results |
| Price/Earnings | -38.85x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of THEMIS MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹936.7 Cr] as on Dec 26,2025
(/) Earnings [ ₹-24.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -38.85x ]
Thus, for THEMIS MEDICARE , the investors are currently willing to pay -38.85 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of THEMIS MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of THEMIS MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of THEMIS MEDICARE
PE Ratio Performance Analysis for THEMIS MEDICARE
- THEMIS MEDICARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 19.07x.
- THEMIS MEDICARE 's operated at median p/e ratio of 1.89x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, THEMIS MEDICARE 's p/e ratio peaked in Mar2024 at 46.31x.
- THEMIS MEDICARE 's p/e ratio hit its five-year low in Mar2021 of 0.72x.
How does THEMIS MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| THEMIS MEDICARE | -24.11 | -38.85 | 936.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 39.22 | 412,494.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.62 | 170,514.0 |
| CIPLA LTD | 5,453.86 | 22.29 | 121,574.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.30 | 129,044.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.51 | 105,919.0 |
| MANKIND PHARMA LTD | 1,767.06 | 51.21 | 90,491.0 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.44 | 91,718.2 |
| LUPIN LTD | 4,347.53 | 22.20 | 96,519.3 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.32 | 70,041.8 |
| ABBOTT INDIA LTD | 1,508.95 | 40.66 | 61,350.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs THEMIS MEDICARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -38.85x |
| Max industry PE | 68.62x |
| Median industry PE | 22.29x |
| Average industry PE | 29.36x |
You may also like the below Video Courses